Company / Revenue per Share
Cyclerion Therapeutics, Inc. Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.81
FY2025
5-year range
$0.00 / $0.81
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2024 to $0.81 in FY2025.
Based on SEC 10-K filings.
0.81 in FY2025 with a 5-year CAGR of +37.9%.
Improved from $0.14 to $0.81 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +392.0%
- 5-Year CAGR
- +37.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.81 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.14 | +1895.0% |
| FY2022 | $0.01 | -90.9% |
| FY2021 | $0.08 | -53.8% |
| FY2020 | $0.16 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026